Literature DB >> 3560322

Penile prosthesis surgery in the treatment of impotence in the immunosuppressed man.

A A Sidi, W Peng, C Sanseau, P H Lange.   

Abstract

Thirteen male diabetic patients on immunosuppressive therapy following organ transplantation underwent implantation of 14 penile prostheses for treatment of organic impotence. Except for extended parenteral antibiotic therapy and increased steroid coverage postoperatively, the preoperative, perioperative and postoperative management in all 13 patients was similar to that of routine penile implantation procedures. No infections or erosion complications were encountered. We conclude that the penile prosthesis should be included in the armamentarium for the treatment of impotence in the immunosuppressed man.

Entities:  

Mesh:

Year:  1987        PMID: 3560322     DOI: 10.1016/s0022-5347(17)44173-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Penile implant infections: prevention and treatment.

Authors:  John J Mulcahy
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

2.  Current approach to the treatment of penile implant infections.

Authors:  John J Mulcahy
Journal:  Ther Adv Urol       Date:  2010-04

Review 3.  Minimizing Penile Implant Infection: A Literature Review of Patient and Surgical Factors.

Authors:  Bradley Holland; Tobias Kohler
Journal:  Curr Urol Rep       Date:  2015-12       Impact factor: 3.092

4.  Penile prosthesis infection: progress in prevention and treatment.

Authors:  John J Mulcahy
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 5.  Penile implant infection factors: a contemporary narrative review of literature.

Authors:  Bryce A Baird; Kevin Parikh; Gregory Broderick
Journal:  Transl Androl Urol       Date:  2021-10

Review 6.  Penile implant infection prevention part 1: what is fact and what is fiction? Wilson's Workshop #9.

Authors:  Tobias S Köhler; Lexiaochuan Wen; Steven K Wilson
Journal:  Int J Impot Res       Date:  2020-07-21       Impact factor: 2.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.